11月7日 - IO Biotech, Inc.:*IO Biotech在2025年癌症免疫治疗学会年会上展示了额外治疗癌症疫苗候选者的临床前数据。 ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com)) 来源日期/时间 = 07-NOV-2025 14:00:01.563 GMT
11月7日 - IO Biotech, Inc.:*IO Biotech在2025年癌症免疫治疗学会年会上展示了额外治疗癌症疫苗候选者的临床前数据。 ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com)) 来源日期/时间 = 07-NOV-2025 14:00:01.563 GMT
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.